It’s infamous as a “silent disease,” with symptoms that rarely make themselves known until too late. But one Conquer Cancer-funded researcher may have found a way to improve the odds, even for patients with advanced-stage pancreatic cancer.

Patient participation in clinical trials is vital to advancing cancer research. Too often, however, a communication breakdown occurs between the physician and the patient. The result? Too many patients may never fully understand the research they took part in or the outcomes it yielded.